Evexia Lifecare Ltd is an emerging player in the pharmaceutical and healthcare industry, focusing on the development and distribution of a wide range of medicines and healthcare products. The company aims to deliver high-quality and affordable healthcare solutions to improve the well-being of its customers. Evexia Lifecare Share Price on BOM as of 8 January 2025 is 3.33 INR. Here will provide you more details on Evexia Lifecare Share Price Target 2025, 2026 to 2030.
Evexia Lifecare Ltd: Market Overview
- Open: ₹3.40
- High: ₹3.43
- Low: ₹3.30
- Previous Close: ₹3.38
- Volume: 6,225,336
- Value (Lacs): ₹205.44
- VWAP: ₹3.32
- UC Limit: ₹3.71
- LC Limit: ₹3.05
- 52 Week High: ₹4.40
- 52 Week Low: ₹1.94
- Mkt Cap (Rs. Cr.): ₹368
- Face Value: ₹1
Evexia Lifecare Share Price Chart
Evexia Lifecare Share Price Target Tomorrow 2025 To 2030
| Evexia Lifecare Share Price Target Years | Share Price Target |
| 2025 | ₹5 |
| 2026 | ₹7 |
| 2027 | ₹9 |
| 2028 | ₹11 |
| 2029 | ₹13 |
| 2030 | ₹15 |
Evexia Lifecare Share Price Target 2025
Evexia Lifecare share price target 2025 Expected target could be ₹5. Here are 4 Key Factors Affecting Growth for “Evexia Lifecare Share Price Target 2025”:
- Expansion of Product Portfolio: Introducing new and innovative pharmaceutical and healthcare products could drive higher revenues and market share, positively impacting the company’s growth.
- Rising Healthcare Demand: Increasing awareness about healthcare and growing demand for affordable medicines may provide growth opportunities, especially in domestic and emerging markets.
- Strategic Partnerships: Collaborations with other pharmaceutical companies and healthcare providers can boost Evexia Lifecare’s distribution network and R&D capabilities, supporting long-term growth.
-
Regulatory Approvals and Compliance: Timely approvals for new drugs and adherence to international quality standards will be crucial for maintaining trust and expanding globally.
Evexia Lifecare Share Price Target 2030
Evexia Lifecare share price target 2030 Expected target could be ₹15. Here are 4 Risks and Challenges for “Evexia Lifecare Share Price Target 2030”:
- Regulatory Hurdles: Strict compliance requirements and delays in obtaining approvals for new products could hinder the company’s growth and product launches in global markets.
- Market Competition: Intense competition from established pharmaceutical companies and new entrants may pressure pricing and limit market share expansion.
- Dependence on R&D Success: The company’s growth heavily relies on successful R&D outcomes. Failures in drug development or clinical trials could impact its financial performance and investor confidence.
-
Economic and Geopolitical Factors: Global economic uncertainties, currency fluctuations, and trade restrictions could affect export revenues and overall profitability.
Evexia Lifecare Ltd Shareholding Pattern
- Promoters: 5.87%
- FII: 1.49%
- DII: 0.17%
- Public: 92.47%
Evexia Lifecare Ltd Financials
| (INR) | 2024 | Y/Y change |
| Revenue | 562.70M | -19.10% |
| Operating expense | 40.48M | 9.56% |
| Net income | 13.77M | 106.52% |
| Net profit margin | 2.45 | 155.21% |
| Earnings per share | — | — |
| EBITDA | 19.50M | 233.79% |
| Effective tax rate | 28.62% | — |
Read Also:- PVP Ventures Share Price Target Tomorrow 2025 To 2030 – Stock Market Update
